Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Statistics in Medicine
|
July 20, 2007
Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval
G Frank Liu, G Ray Zhu, Lu Cui
Therapeutic Innovation & Regulatory Science
|
December 10, 2020
Combined-Indications Significance Level of Multiple Related Indications Developed Simultaneously
Jiacheng Yuan, Ray Zhu, Daniel Jia, et al.
Journal of Biopharmaceutical Statistics
|
January 8, 2019
Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls
Jiacheng Yuan, Jeen Liu, Ray Zhu, et al.
Diabetes Technology & Therapeutics
|
June 1, 2006
Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine
John Gerich, Reinhard H A Becker, Ray Zhu, et al.
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Clinical Study Design to Assess Both Short- and Long-term Efficacy in Addition to Group Sequential Test on Safety
Jiacheng Yuan, Peter Mesenbrink, Jihao Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 21, 2025
Cartesian equivariant representations for learning and understanding molecular orbitals
Daniel S King, Daniel Grzenda, Ray Zhu, et al.
Journal of the American Chemical Society
|
December 21, 2025
Discovery of Stacking Heterogeneity, Layer Buckling, and Residual Water in COF-999-NH<sub>2</sub> and Implications on CO<sub>2</sub> Capture
Hilal Daglar, Zihui Zhou, Ray Zhu, et al.
Statistics in Medicine
|
May 1, 2018
Performance of intraclass correlation coefficient (ICC) as a reliability index under various distributions in scale reliability studies
Shraddha Mehta, Rowena F Bastero-Caballero, Yijun Sun, et al.
Eclinicalmedicine
|
July 29, 2025
Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial
Alexander Rumyantsev, Lixia Wang, Shixia Wang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Statistics in Medicine
|
July 20, 2007
Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval
G Frank Liu, G Ray Zhu, Lu Cui
Therapeutic Innovation & Regulatory Science
|
December 10, 2020
Combined-Indications Significance Level of Multiple Related Indications Developed Simultaneously
Jiacheng Yuan, Ray Zhu, Daniel Jia, et al.
Journal of Biopharmaceutical Statistics
|
January 8, 2019
Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls
Jiacheng Yuan, Jeen Liu, Ray Zhu, et al.
Diabetes Technology & Therapeutics
|
June 1, 2006
Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine
John Gerich, Reinhard H A Becker, Ray Zhu, et al.
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Clinical Study Design to Assess Both Short- and Long-term Efficacy in Addition to Group Sequential Test on Safety
Jiacheng Yuan, Peter Mesenbrink, Jihao Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 21, 2025
Cartesian equivariant representations for learning and understanding molecular orbitals
Daniel S King, Daniel Grzenda, Ray Zhu, et al.
Journal of the American Chemical Society
|
December 21, 2025
Discovery of Stacking Heterogeneity, Layer Buckling, and Residual Water in COF-999-NH<sub>2</sub> and Implications on CO<sub>2</sub> Capture
Hilal Daglar, Zihui Zhou, Ray Zhu, et al.
Statistics in Medicine
|
May 1, 2018
Performance of intraclass correlation coefficient (ICC) as a reliability index under various distributions in scale reliability studies
Shraddha Mehta, Rowena F Bastero-Caballero, Yijun Sun, et al.
Eclinicalmedicine
|
July 29, 2025
Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial
Alexander Rumyantsev, Lixia Wang, Shixia Wang, et al.
Page
of 1